Skip to main content

Advertisement

SpringerLink
Log in

Noninvasive Visualization of Pharmacokinetics, Biodistribution and Tumor Targeting of Poly[N-(2-hydroxypropyl)methacrylamide] in Mice Using Contrast Enhanced MRI

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

To study a non-invasive method of using contrast enhanced magnetic resonance imaging (MRI) to visualize the real-time pharmacokinetics, biodistribution and tumor accumulation of paramagnetically labeled poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) copolymer conjugates with different molecular weights and spacers in tumor-bearing mice.

Materials and Methods

Paramagnetically labeled HPMA copolymer conjugates were synthesized by free radical copolymerization of HPMA with monomers containing a chelating ligand, followed by complexation with Gd(OAc)3. A stable paramagnetic chelate, Gd-DO3A, was conjugated to the copolymers via a degradable spacer GlyPheLeuGly and a non-degradable spacer GlyGly, respectively. The conjugates with molecular weights of 28, 60 and 121 kDa and narrow molecular weight distributions were prepared by fractionation with size exclusion chromatography. The conjugates were injected into athymic nude mice bearing MDA-MB-231 human breast carcinoma xenografts via a tail vein. MR images were acquired before and at various time points after the injection with a 3D FLASH sequence and a 2D spin-echo sequence at 3T. Pharmacokinetics, biodistribution and tumor accumulation of the conjugates were visualized based on the contrast enhancement in the blood, major organs and tumor tissue at various time points. The size effect of the conjugates was analyzed among the conjugates.

Results

Contrast enhanced MRI resulted in a real-time, three-dimensional visualization of blood circulation, pharmacokinetics, biodistribution and tumor accumulation of the conjugates, and the size effect on these pharmaceutical properties. HPMA copolymer conjugates with high molecular weight had a prolonged blood circulation time and high passive tumor targeting efficiency. Non-biodegradable HPMA copolymers with molecular weights higher than the threshold of renal filtration demonstrated higher efficiency for tumor drug delivery than biodegradable poly(L-glutamic acid).

Conclusions

Contrast enhanced MRI is an effective method for non-invasive visualization of in vivo properties of the paramagnetically labeled polymer conjugates in preclinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. J. Kopecek, P. Kopeckova, T. Minko, and Z.-R. Lu. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur. J. Pharm. Biopharm. 50:61–81 (2000).

    Article  PubMed  CAS  Google Scholar 

  2. B. Rihova and K. Kubackova. Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers. Curr. Pharm. Biotechnol. 4:311–322 (2003).

    Article  PubMed  CAS  Google Scholar 

  3. H. Maeda, L. W. Seymour, and Y. Miyamoto. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug. Chem. 3:351–362 (1992).

    Article  PubMed  CAS  Google Scholar 

  4. R. Haag and F. Kratz. Polymer therapeutics: concepts and applications. Angew. Chem. Int. Ed. Engl. 45:1198–1215 (2006).

    Article  PubMed  CAS  Google Scholar 

  5. Z.-R. Lu, J.-G. Shiah, P. Kopeckova, and J. Kopecek. Polymerizable Fab’ antibody fragments targeted photodynamic cancer therapy in nude mice. STP Pharm. Sci. 13:69–75 (2003).

    CAS  Google Scholar 

  6. M. V. Pimm, A. C. Perkins, J. Strohalm, K. Ulbrich, and R. Duncan. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma. J. Drug Target. 3:375–383 (1996).

    PubMed  CAS  Google Scholar 

  7. P. J. Julyan, L. W. Seymour, D. R. Ferry, S. Daryani, C. M. Boivin, J. Doran, M. David, D. Anderson, C. Christodoulou, A. M. Young, S. Hesslewood, and D. J. Kerr. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. J. Control Release. 57:281–290 (1999).

    Article  PubMed  CAS  Google Scholar 

  8. M. Kissel, P. Peschke, V. Subr, K. Ulbrich, J. Schuhmacher, J. Debus, and E. Friedrich. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. PDA J. Pharm. Sci. Technol. 55:191–201 (2001).

    PubMed  CAS  Google Scholar 

  9. A. Mitra, A. Nan, H. Ghandehari, E. McNeill, J. Mulholland, and B. R. Line. Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution. Pharm. Res. 21:1153–1159 (2004).

    Article  PubMed  CAS  Google Scholar 

  10. M. V. Pimm, A. C. Perkins, J. Strohalm, K. Ulbrich, and R. Duncan. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma. J. Drug Target. 3:385–390 (1996).

    PubMed  CAS  Google Scholar 

  11. D. Wang, S. C. Miller, M. Sima, D. Parker, H. Buswell, K. C. Goodrich, P. Kopeckova, and J. Kopecek. The arthrotropism of macromolecules in adjuvant-induced arthritis rat model: a preliminary study. Pharm. Res. 21:1741–1749 (2004).

    Article  PubMed  CAS  Google Scholar 

  12. F. Ye, T. Ke, E.-K. Jeong, X. Wang, Y. Sun, M. Johnson, and Z.-R. Lu. Noninvasive visualization of in vivo drug delivery of poly(L-glutamic acid) using contrast-enhanced MRI. Mol. Pharmaceutics. 3:507–515 (2006).

    Article  CAS  Google Scholar 

  13. K. Ulbrich, V. Subr, J. Strohalm, D. Plocova, M. Jelinkova, and B. Rihova. Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation. J. Control Release. 64:63–79 (2000).

    Article  PubMed  CAS  Google Scholar 

  14. T. Ke, Y. Feng, J. Guo, D. L. Parker, and Z.-R. Lu. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DOTA conjugates for contrast enhanced MR imaging. Magn. Reson. Imaging. 24:931–940 (2006).

    Article  PubMed  CAS  Google Scholar 

  15. T. Kaneshiro, T. Ke, E. K. Jeong, D. L. Parker, and Z.-R. Lu. (Gd-DTPA)-(L-cystine bisalkylamide) copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging. Pharm. Res. 23:1285–1294 (2006).

    Article  PubMed  CAS  Google Scholar 

  16. Y. Feng, Y. Zong, T. Ke, and Z.-R. Lu. Pharmacokinetics and blood pool contrast enhancement of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers. Pharm. Res. 23:1736–1742 (2006).

    Article  PubMed  CAS  Google Scholar 

  17. P. Caravan, J. J. Ellison, T. J. McMurry, and R. B. Lauffer. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99:2293–2352 (1999).

    Article  PubMed  CAS  Google Scholar 

  18. X. Wang, Y. Feng, T. Ke, M. Schabel, and Z.-R. Lu. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent. Pharm. Res. 22:596–602 (2005).

    Article  PubMed  CAS  Google Scholar 

  19. P. L. Choyke, A. J. Dwyer, and M. V. Knopp. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging. 17:509–520 (2003).

    Article  PubMed  Google Scholar 

  20. F. M. Veronese, O. Schiavon, G. Pasut, R. Mendichi, L. Andersson, A. Tsirk, J. Ford, G. Wu, S. Kneller, J. Davies, and R. Duncan. PEG-doxorubicin Conjugates: Influence of Polymer Structure on Drug Release, in Vitro Cytotoxicity, Biodistribution, and Antitumor Activity. Bioconjug. Chem. 16:775–784 (2005).

    Article  PubMed  CAS  Google Scholar 

  21. L. W. Seymour, Y. Miyamoto, H. Maeda, M. Brereton, J. Strohalm, K. Ulbrich, and R. Duncan. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur. J. Cancer. 31A:766–770 (1995).

    Article  PubMed  CAS  Google Scholar 

  22. P. Rejmanova, J. Kopecek, R. Duncan, and J. B. Lloyd. Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. Biomaterials. 6:45–48 (1985).

    Article  PubMed  CAS  Google Scholar 

  23. D. R. Messroghli, S. Plein, D. M. Higgins, K. Walters, T. R. Jones, J. P. Ridgway, and M. U. Sivananthan. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Radiology. 238:1004–1012 (2006).

    Article  PubMed  Google Scholar 

  24. E. L. So. Integration of EEG, MRI, and SPECT in localizing the seizure focus for epilepsy surgery. Epilepsia. 41(Suppl 3):S48–S54 (2000).

    Article  PubMed  Google Scholar 

  25. M. D. Seemann. Whole-body PET/MRI: the future in oncological imaging. Technol. Cancer Res Treat. 4: 577–582 (2005).

    PubMed  Google Scholar 

  26. S. W. Zielhuis, J. H. Seppenwoolde, V. A. Mateus, C. J. Bakker, G. C. Krijger, G. Storm, B. A. Zonnenberg, A. D. Schip, G. A. Koning, and J. F. Nijsen. Lanthanide-loaded liposomes for multimodality imaging and therapy. Cancer Biother. Radiopharm. 21:520–527 (2006).

    Article  PubMed  CAS  Google Scholar 

  27. J. G. Shiah, M. Dvorak, P. Kopeckova, Y. Sun, C. M. Peterson, and J. Kopecek. Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur. J. Cancer. 37:131–139 (2001).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported in part by NIH grant R01 CA097465. We thank Ms. Melody Johnson for the technical help in MRI data acquisition.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, 421 Wakara Way, Suite 318, Salt Lake City, Utah, 84108, USA

    Yanli Wang, Furong Ye, Yongen Sun & Zheng-Rong Lu

  2. Department of Radiology, University of Utah, Salt Lake City, Utah, 84108, USA

    Eun-Kee Jeong & Dennis L. Parker

Authors
  1. Yanli Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Furong Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eun-Kee Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yongen Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dennis L. Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zheng-Rong Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zheng-Rong Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Ye, F., Jeong, EK. et al. Noninvasive Visualization of Pharmacokinetics, Biodistribution and Tumor Targeting of Poly[N-(2-hydroxypropyl)methacrylamide] in Mice Using Contrast Enhanced MRI. Pharm Res 24, 1208–1216 (2007). https://doi.org/10.1007/s11095-007-9252-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-007-9252-1

Key words

Search

Navigation